Skip to content
Screener

iRadimed IRMD Q1 2025 earnings

Reported May 5, 2025 · Before market open

Revenue$19.5MBeat by $178.6K
EPS$0.42Miss by $0.01
Revenue estimate$19.3M
EPS estimate$0.43

Next report

Nov 2, 2026 (in a month)
Revenue estimate$23.2M
EPS estimate$0.52

Financials

Q1 2025

Income statement

See full
Revenue$19.5M+10.9%
Gross profit$14.8M+10.9%
Operating income$5.4M+14.4%
Net income$4.7M+13.3%
EPS (diluted)$0.37+15.6%

Balance sheet

See full
Cash & equivalents$50.3M+11.5%
Total debt$59.2K-96.9%
Total equity$90.1M+18.3%
Total assets$101.7M+15.6%

Cash flow

See full
Operating cash flow$4.3M+10.5%
CapEx$3.7M+1,266%
Free cash flow$595.0K-83.5%

Valuation & ratios

Valuation

as of 03/31/25
See full
Market cap$667.29M+19.8%
Enterprise value$617.02M+20.1%
P/E33.7×+2.6×
P/S8.9×+0.6×

Profitability

See full
Gross margin76.9%+0.3pp
Operating margin30.1%-0.6pp
Net margin26.3%-0.2pp
FCF margin19.4%+2.6pp

Returns & leverage

See full
Return on equity23.8%-1.7pp
Debt / equity0×0.0×
Current ratio8.9×-0.6×

Segments

By product

See full
MRI Compatible Patient Vital Signs Monitoring Systems$6.5M—
MRI Compatible IV Infusion Pumps$6.0M—
Ferro Magnetic Detection Systems$418.0K—

FAQ

When did iRadimed report Q1 2025 earnings?
iRadimed (IRMD) reported Q1 2025 earnings on May 5, 2025 before market open.
What were iRadimed's Q1 2025 revenue and EPS?
iRadimed reported revenue of $19.5M and eps of $0.42 for Q1 2025.
Did iRadimed beat estimates in Q1 2025?
Revenue beat the consensus estimate of $19.3M by $178.6K. EPS missed the consensus estimate of $0.43 by $0.01.
How did iRadimed's Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 10.9% from $17.6M a year earlier and eps grew 16.7% from $0.36.
Where can I find iRadimed's Q1 2025 SEC filings?
You can read the 8-K earnings release (0001558370-25-006220) and the 10-Q periodic report (0001558370-25-006308) directly on SEC EDGAR. The filing index links above go to sec.gov.